Back
Lexicon Pharmaceuticals Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
LXRX
Lexicon Pharmaceuticals
Last Price:
0.77
Seasonality Move:
23.34%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Lexicon Pharmaceuticals Stock Forecast
-
Is Lexicon Pharmaceuticals Stock Undervalued?
The current Lexicon Pharmaceuticals [LXRX] share price is $0.81. The Score for LXRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - LXRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Lexicon Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Lexicon Pharmaceuticals Stock Rating
Data Unavailable
Lexicon Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lexpharma.com
52-Week Data
52-Week High:
3.73
52-Week Low:
0.91
Prediction Charts
Market Cap:
291.87M
Price in USD:
0.81
Volume:
3.08M
Beta:
1.56
Technical Analysis
SMA50:
1.56
SMA100:
1.69
SMA200:
1.87
52-Wk Change:
-31.58%
Stock Predictions
-
Is Lexicon Pharmaceuticals stock public?
Yes, Lexicon Pharmaceuticals is a publicly traded company. -
What is the Lexicon Pharmaceuticals stock quote today?
The Lexicon Pharmaceuticals stock price is 0.81 USD today. -
How to buy Lexicon Pharmaceuticals stock online?
You can buy Lexicon Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 1.20 | 1.22 | 1.38 | 1.16 |
| Nov-4 | 1.22 | 1.21 | 1.23 | 1.20 |
| Nov-5 | 1.20 | 1.19 | 1.20 | 1.01 |
| Nov-6 | 1.18 | 1.21 | 1.23 | 1.15 |
| Nov-7 | 1.22 | 1.30 | 1.35 | 1.18 |
| Nov-8 | 1.30 | 1.27 | 1.32 | 1.20 |
| Nov-11 | 1.26 | 1.27 | 1.31 | 1.23 |
| Nov-12 | 1.26 | 1.19 | 1.26 | 1.18 |
| Nov-13 | 1.18 | 1.08 | 1.19 | 1.05 |
| Nov-14 | 1.08 | 1.06 | 1.08 | 1.05 |
| Nov-15 | 1.08 | 0.98 | 1.08 | 0.97 |
| Nov-18 | 0.99 | 0.91 | 1.00 | 0.91 |
| Nov-19 | 0.91 | 0.88 | 0.91 | 0.86 |
| Nov-20 | 0.88 | 0.81 | 0.90 | 0.79 |
Lexicon Pharmaceuticals Earnings
Data Unavailable
Lexicon Pharmaceuticals Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.14 per share.
* Lexicon Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.